SKSergey Krapivin

Sergey Krapivin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergey Krapivin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictors of one-year survival after ischaemic stroke

    by S. P. Kulikova, I. Yu. Polyakova, E. V. Kuzmicheva, A. A. Kulesh, S. A. Mekhryakov, A. M. Kulesh, S. V. Krapivin, Yu. V. Karakulova

    Predicting the outcome of ischaemic stroke (IS) is a complex task, as mortality and disability depend on many factors, including age, gender, type and severity of stroke, and comorbidities. Survival rates also vary between countries depending on genetic characteristics and differences in the organisation of healthcare systems.Objective: to search for predictors of one-year survival after IS in a sample of patients from the Perm region.Material and methods. The study included 254 patients who had suffered an IS. Seventy-five parameters obtained during routine clinical examination were analysed, including information on the subtype and severity of the stroke, the size and location of the lesion, neurological disorders, comorbidities, and other factors. Relevant features were selected using the WEKA programme, and the selected features were used in a predictive model based on logistic regression.Results. The following factors have been identified as significant predictors of annual survival in patients who have undergone IS (the sign of the coefficient reflects the relative contribution of the factor to the model and its positive or negative effect): age (-0.02), degree of neurological deficit on the NIHSS scale at discharge (-0.06), haemoglobin level (0.01), infarction in the anterior choroidal artery basin (0.74), recurrent stroke within the following year (-0.02) and cardioembolic stroke subtype (-0.32). The accuracy of the logistic model was 84% with 10-fold cross-validation.Conclusion. In the model predicting one-year survival after IS, other factors have been identified in addition to age, which is usually associated with a less favourable prognosis. Further multicentre studies are needed to confirm the reliability of the proposed model.


  • Ischemic stroke on the background of thrombosis of sinus of Valsalva aneurysm

    by S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, S. Krapivin

    Introduction. The prevalence of sinus of Valsalva aneurysm (SOVA) in the general population is up to 0.09%, and among all congenital heart defects from 0.1 to 3.5%. One of the complications of this pathology is the development of cerebral embolism. Aim. To present a clinical case of ischemic stroke in a young patient with a rare cardiac pathology. Material and methods. The article presents a description of a clinical case of the development of ischemic stroke due to cerebral embolism from a thrombosed SOVA. A review of all published cases on the clinical significance of SOVA thrombosis in the development of stroke was conducted, and the PubMed database of medical and biological publications was analyzed. Results. A 19-years old patient without chronic diseases or bad habits was hospitalized at the vascular center for thrombectomy from the right middle cerebral artery. After successful reperfusion therapy, a diagnostic search was initiated. Transthoracic echocardiography revealed thrombosis of SOVA. During anticoagulant therapy, control transesophageal echocardiography demonstrated thrombus lysis. The patient underwent delayed resection of the SOVA. Conclusion. The study of the problem of embolic complications against the background of SOVA is low due to the extremely rare prevalence of this anomaly. Echocardiography is a key method for primary visualization of SOVA and its dynamic monitoring. There are no regulated tactics for managing patients with SOVA thrombosis.


  • Transient global amnesia due to a rare cardiac anomaly

    by S. A. Mehryakov, A. A. Kulesh, N. A. Kaileva, S. Krapivin

    Introduction. Left atrial septal pouch (LASP) is a rare, poorly understood cause of embolic cryptogenic stroke. Along with this, there is no understanding of the role of this pathology in the development of transient global amnesia (TGA) due to possible embolism.Aim. To present a clinical case of a patient with TGA and LASP.Material and methods. This article presents a description of the clinical case of a young patient with TGA and a concomitant anomaly of the interatrial septum in the form of LASP and patent foramen ovale (PFO). In order to search for published clinical cases and reviews on the pathogenetic significance of LASP, the database of medical and biological publications PubMed was analyzed.Results. Patient O., 39-year old, with a history of migraine due to provoking factors (Valsalva maneuver), suff ered an episode of TGA. Angiography did not reveal any pathology. There were no acute infarctions according to magnetic resonance imaging. During the diagnostic search, transesophageal echocardiography revealed a combined anomaly of the interatrial septum in the form of a combination of LASP with PFO.Conclusion. LASP is a rare and little-studied anomaly of the formation of the interatrial septum. Transthoracic echocardiography is not a sensitive method for identifying this pathology. The imaging method of choice is TEE. If the presence of LASP is suspected, clinicians should be aware of the need to exclude concomitant interatrial communications using a bubble study.

  • Open Access

    Migraine with prolonged aura vs migraine-associated stroke: a case series. Case report

    by Aleksey A. Kulesh, Natalia L. Starikova, Dmitry A. Demin, Sergey Krapivin, Sergei A. Mekhriakov, Nadezhda A. Kaileva, Marina V. Lezhikova, Мехряков Сергей Александрович

    The article presents three clinical cases of patients with migraine with aura and long-term focal symptoms without the formation of ischemic foci. A case of migraine-associated stroke is presented for comparison. The presented cases indicate that admission to the hospital of a patient with a history of migraine and a focal neurological deficit is a challenging clinical situation that requires individualization of diagnostic and therapeutic tactics. In the presence of a prolonged aura, CT perfusion, and diffusion-weighted magnetic resonance imaging, can contribute to an informed clinical decision. The MRI findings should be interpreted cautiously since transient cortical edema may be associated with aura prolongation. If it is impossible to differentiate reliably between migraine and stroke in a short time, intravenous thrombolysis should be performed.


  • Comparison of the effectiveness of non-immunogenic staphylokinase and alteplase for intravenous thrombolysis in ischemic stroke: analysis of hospital registry data

    by A.A. Kulesh, L.I. Syromyatnikova, S. Krapivin, P.V. Astanin

    Objective. To compare the effectiveness and safety of the use of non-immunogenic staphylokinase (NS) and alteplase (AP) for intravenous thrombolysis (IT) for ischemic stroke (IS) in real clinical practice at a regional vascular center. Material and methods. Data from 100 patients with IS who received IT with NS and 100 patients who received IT with AP for the period 2022—2023 were analyzed. The groups were comparable on sociodemographic parameters, cardiovascular risk factors and diseases, and stroke characteristics. Results. Door-to-needle time was 17 (13—22) min in the NS group and 38 (33—42) min in the AP group (p<0.001). During control neuroimaging, a cerebral infarction was detected in 46% of patients in the NS group and 61% of patients in the AP group (OR 0.479 [0.263; 0.875], p=0.035). When performing IT with NS, an NIHSS score of 0 points (no neurological deficit) was observed twice as often (OR 2.202 [1.079; 4.504], p=0.023). The incidence of hemorrhagic transformation, including symptomatic, as well as hospital mortality did not differ. Conclusion. IT with NS is associated with a lower probability of cerebral infarction and greater positive dynamics of the neurological status in comparison with the use of AP already within the first stage of treatment and rehabilitation.


  • Open Access

    Transient global amnesia

    by A. A. Kulesh, D. A. Demin, N. A. Kayleva, S. A. Mekhryakov, S. V. Krapivin

    Transient global amnesia (TGA) is a benign, stress-induced neurological syndrome associated with reversible hippocampal dysfunction that manifests as isolated, predominantly anterograde amnesia. Since it is impossible to make a definitive diagnosis of TGA when the patient is admitted to hospital, the primary condition should be interpreted as an acute cerebrovascular accident, which implies a mandatory neuroimaging examination and clarification of the question of thrombolysis according to general principles. When taking a medical history, attention should be paid to the presence of predisposing conditions and triggers: migraine, chronic and acute stress, physical activity, sudden changes in temperature, Valsalva maneuver, coitus, medical procedures. If amnesia does not resolve within 24 hours, a differential diagnosis with stroke, Wernicke–Korsakoff encephalopathy, limbic encephalitis, intoxication and psychogenic (dissociative) amnesia is required. If the symptoms resolve within 24 hours and the classic diagnostic criteria are met, magnetic resonance imaging of the brain in diffusion-weighted mode is performed on days 2 to 4 in order to detect pinpoint zones of diffusion restriction in the hippocampus. If these lesions are visible and a typical medical history is available, the diagnosis of TGA can be made; if no lesions are present, the diagnosis is probable. In the absence of lesions and an atypical history of TGA, differentiation from transient epileptic or dissociative amnesia and transient ischemic attack is required.


  • Open Access

    Experience with non-immunogenic staphylokinase for intravenous thrombolysis in ischemic stroke: analysis of hospital registry data

    by A. A. Kulesh, L. I. Syromyatnikova, S. Krapivin

    Introduction. Intravenous thrombolysis (IT) is the primary method of reperfusion therapy for ischemic stroke. Over the past couple of years, there has been a global trend towards the predominant use of the bolus forms of thrombolytic drugs that is caused by necessity to increase the reperfusion therapy rate to achieve its best outcomes.Aim. To evaluate the efficacy and safety of the use of non-immunogenic staphylokinase for IT in ischemic stroke in real-world clinical practice of the regional vascular center.Materials and methods. The clinical outcomes of the cohort of 50 patients who underwent IT with non-immunogenic staphylokinase were analysed.Results. The age of the patients ranged from 46 to 94 years and averaged 71.8 ± 10.0 years; 22% of patients were over 80 years of age. The NIHSS score at admission varied from 3 to 23 scores and averaged 11 (8-14) scores. 36% of patients had large artery occlusions. 14% of patients received a step-wise reperfusion therapy. The median door-to-needle time was 23 (18-26) minutes. 52% of patients didn’t develop any infarction area during control neuroimaging. 62% of patients required no further rehabilitation. Hospital mortality was 12%. 18% of patients developed hemorrhagic conversion mainly in the form of hemorrhagic infarction. 1 patient had a symptomatic hemorrhagic conversion. Major bleeding and angioedema were not observed.Conclusion. The analysis of 50 consecutive cases of IT in ischemic stroke using non-immunogenic staphylokinase indicates the high efficiency and safety of this method of reperfusion therapy.